Resmetirom is one of only two drugs in the pipeline focused on thyroid hormone functions and having good success. Now in a phase 3 trial.
MADRIGAL PRESENTS, Resmetirom a leade... - Living with Fatty...
MADRIGAL PRESENTS, Resmetirom a leader in NAFLD/NASH drug development
Written by
nash2
Partner
To view profiles and participate in discussions please or .
3 Replies
•
Hi Wayne - Loved reading your post. I’m currently in the year long Madrigal Pharmaceuticals phase 3 clinical trial of Resmetirom! I started in the trial October 2020. Of course I don’t know if I’m on placebo or the Resmetirom. I just replied to your email about this a little earlier today. I’m excited about this trial. My next appointment in July is week 40 so I’m over half way through.
Char
Thanks for sharing Wayne. It is really nice knowing that NAFLD/NASH drug development is an active research field
Hi. Just to say that I am now on that trial. Been on the tablets now for 2 months so a long way to go.Robbo
Not what you're looking for?
You may also like...
Madrigal drug Resmetirom approved by FDA
https://www.fattyliverfoundation.org/a_new_dawn_in_liver_health_fatty_liver_foundation_applauds_brea
What is the difference between NAFLD and NASH?
I was just diagnosed with NAFLD. I already have PBC and cirrhosis because of it, diagnosed 6 years...
Will You Take Our Survey Seeking NAFLD/NASH Patient Voices?
most are only recognized in the late stages. We believe that is wrong but a first step is to have...
Dr will not prescribe new Nash drug Rezdiffra
not urgent for the drug and I should wait 1 year for another Fibroscan. I feel I have already lost...